Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice
Anti-CD20 antibody therapy is used for both cancer and autoimmune disease but has been shown to be associated with PneumocystisPneumocystis
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2021-06-01
|
| Series: | mSphere |
| Online Access: | https://journals.asm.org/doi/10.1128/mSphere.01144-20 |